OS
SEC Insider//CIK 0001615840
O'Loughlin Steve
CIK 00016158403 companiesHOUSTON, TX
Transactions
22
Companies
3
Filings
11
CIK
0001615840
Recent Transactions
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
Options to purchase common stock
2019-07-12$0.23/sh+400,000→ 400,000 total - Purchase
- Award
Options to purchase common stock
2018-07-13$0.78/sh+265,000→ 265,000 total - Purchase
- Other
- Other
- Other
- Purchase
Companies
3Recent Filings
11- 4
O'Loughlin Steve
Mar 4, 2026
- 4
O'Loughlin Steve
Apr 2, 2025
- 4
O'Loughlin Steve
Dec 29, 2023
- 4
O'Loughlin Steve
Jul 1, 2022
- 4
O'Loughlin Steve
Sep 3, 2021
- 4
O'Loughlin Steve
Aug 14, 2020
- 4
O'Loughlin Steve
Jul 16, 2019
- 4
O'Loughlin Steve
Dec 10, 2018
- 4
O'Loughlin Steve
Jul 17, 2018
- 4
O'Loughlin Steve
Jun 15, 2018
- 4
O'Loughlin Steve
Mar 8, 2018
Address
C/O CNS PHARMACEUTICALS, INC. 100 WEST LOOP SOUTH, SUITE 900
HOUSTON, TX, 77027